ELIC Publishes Paper Showing Open Source System Supports Deep Learning AI and Quantitative Imaging Analyses on Cloud-Based Datasets

The International Association for the Study of Lung Cancer (IASLC), Accumetra, and numerous international CT lung cancer screening researchers published a paper in the Journal of Thoracic Oncology (JTO) showing that the open source Early Lung

Accumetra Publishes Method That Predicts The Bias and Precision Performance of CT Lung Nodule Volume Measurements

Lung imaging researchers from Accumetra, Mount Sinai, and Cleveland Clinic published a manuscript in July indicating for the first time that CT lung volume measurements can be reliably predicted using a new calibration-based analysis method. The

Accumetra Presents a New Lung Nodule Measurement Approach at the 2023 I-ELCAP Meeting in Verona

Accumetra’s founder and CEO Ricardo Avila delivered a presentation on June 29th at the I-ELCAP meeting in Verona, Italy. This presentation announced our newest findings on how to use a combination of AI, computer vision, and

Study Shows 80% Long-Term Survival Results of Low Dose CT Lung Cancer Screening

A 20-year study conducted by the global I-ELCAP team confirms that low dose CT lung cancer screening has an outstanding 80% long-term survival rate. In those 20 years, I-ELCAP has supported around 90,000 lung screening participants,

Accumetra and RSNA/QIBA Launch QIBA Conformance Certification Services at RSNA 2018

RSNA's Quantitative Imaging Biomarkers Alliance (QIBA) and Accumetra have launched the first QIBA Conformance Certification Service for verification of CT small lung nodule volume measurements. This new paid service enables clinical sites to verify that their

Accumetra Presents at the 18th World Conference on Lung Cancer in Yokohoma, Japan

October 14, 2017 Accumetra will present two invited talks, two posters, and is co-author on a Plenary Talk at WCLC 2017:
  • WS 01.12 - Planning for USA Registries for CT Screened Images – What Are Their Objectives?
  • WS 02.15 - Quality Control for Lung Imaging Biomarkers.
  • P2.13-026b - A Novel Ultra Low Cost CT Image Quality Measurement Device.
  • P3.13-035 - Automatic Estimation of Measurement Error on CT Imaging.
  • PL 01.02 - Major Advances in CT Screening: A Radiologist’s Perspective.

Accumetra to Present a Hot Topic Scientific Presentation at the 4th Annual World Congress of Thoracic Imaging

Accumetra will give a Hot Topic scientific presentation on the “Clinical Implications of CT Image Quality Variation in Low Dose Lung Cancer Screening Scans” on Tuesday June 20, 2017 at the 4th Annual World Congress of Thoracic Imaging. The presentation

Accumetra to Present at the 2017 Dialog For Action Conference

Accumetra will present “Crowd-Sourcing Quality in Imaging” on Thursday April 20, 2017 at the Prevent Cancer Foundation’s Dialog For Action conference. The presentation will provide an update on a recent crowd-sourced study showing that low cost and ubiquitously available reference

Accumetra to Present at the 2017 SPIE Medical Imaging Conference

Accumetra will present a poster on a new method for predicting CT lung nodule measurement performance on Wednesday February 15, 2017 at the SPIE Medical Imaging conference. The poster titled “A new method for predicting CT lung nodule volume measurement

Accumetra To Present at the IASLC’s 17th World Conference on Lung Cancer in Vienna, Austria

Accumetra will present a poster (Abstract #6317) on Monday December 5, 2016 at the IASLC’s World Conference on Lung Cancer 2016 that will review the results of the CT Lung Screening Protocol Challenge. The CT Lung Screening Protocol Challenge, conducted

Browse News